Coloplast moves important production to country on tax haven watch list

So far, Coloplast has spent half a billion kroner (USD 75.9m) on establishing two new factories in Costa Rica, which the EU says is close to being a functioning tax haven. The medtech company rejects this as being a factor in the move, saying activities can occur in all countries, and it is openly publishing tax figures – just not for Costa Rica.

Photo: Coloplast/PR

A huge undertaking is well underway, as Coloplast is constructing a new factory in Central American country Costa Rica. While the country isn't quite on the EU's blacklist of non-cooperative jurisdictions for tax purposes, it has made it onto the "grey list."

Coloplast's Vice President for Group Finance Henrik Deneke maintains that according to its commercial policy, the company can be engaged anywhere on the planet and can freely publicize financial figures and reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs